Clinical Trial

Staging Strategies and Their Association With Prognosis and Therapy in Lung Cancer With Cystic Airspaces

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to determine the most accurate tumor size measurement method for T-staging and prognostic assessment in lung cancer with cystic airspaces (LCCA). The main questions it aims to answer are: * What is the optimal T-staging approach for accurately classifying lung cancer with cystic airspaces (LCCA) and predicting patient outcomes? * How do imaging features of cystic lesions correlate with their pathological characteristics? * What is the relationship between imaging features of cystic airspace-associated lesions and patient prognosis? * Can optimizing the T-staging method improve clinical decision-making in patients with LCCA?
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-07-05; most recent amendment 2026-07-06.
Status change: Active, Not Recruiting → Recruiting 2025-11-25
Trial Details
NCT Number NCT07066813
Lead Sponsor Central South University
Conditions Lung Cancer Associated With Cystic Airspaces
Enrollment 500 participants
Start Date 2025-06-01
Primary Completion 2026-05-31 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-08